Signals, Powered By EquityPandit
In collaboration with Serum Institute of India (SII), Cipla has launched Hepatitis B vaccine for adults.
The company has said in a statement that as per Cipla’s co-exclusive agreement with SII, the former will be marketing the vaccine for adults whereas the latter will be marketing it for adults and children.
Umang Vohra, Cipla MD and Global CEO has said that “This agreement will enable Cipla to provide affordable vaccines for a chronic disease like Hepatitis B. Cipla’s strong marketing network and reach will ensure maximum accessibility of the vaccines in India.”
